Gene Query: CPSF2

Dataset Description Geneva Score
Characterization of parental and rociletinib-resistant derived H1975 cell lines 32.66
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 24.61
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 24.61
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 24.07
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 24.07
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 21.75
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 21.18
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 20.56
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 19.56
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 18.94
Region-specific Innate Antiviral Responses of the Human Epididymis 18.2
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 17.94
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 17.89
Transcriptomic analyssis following EHMT1/2 inhibition 17.78
Human cell line and subcutaneous tumor 17.65
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 17.57
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 17.13
CD73 knockdown effect in pancreatic cancer cell lines 17.05
Ribosomal footprinting of MDA-Parental and MDA-LM2 15.63
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 15.48
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 15.39
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 15.15
Ribosomal footprinting of CN34-Parental and CN34-LM1a 15.02
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 14.69
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 14.47
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 14.47
A Unique Epigenomic Landscape Defines Human Erythropoiesis 14.08
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 14.08
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 13.94
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 13.85
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 13.68
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 13.58
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 13.58
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 12.95
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 12.95
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 12.9
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 12.49
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 12.24
TGF-β regulation of miRNA expression in pancreatic cancer 12.22
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 12.02
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 12.02
Crizotinib v. DMSO in SW480 cells 11.92
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 11.84
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 11.66
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 11.66
Sensing self and nonself circular RNAs 11.64
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 11.61
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 11.61
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 11.41
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 11.37
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 11.37
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 11.29
Genes significantly down or Up-regulated upon RNF219 knockdown 11.23
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 11.2
A549 cells and MSR-A549 cells 11.2
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 11.17
RIG-I and MDA5 fRIP during KSHV lytic reactivation 11.1
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 10.97
MYC dependent mRNA translation shapes gene expression and cell biology 10.92
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 10.91
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 10.83
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 10.83
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 10.73
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 10.62
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 10.62
RNAseq Analysis in glioblastoma cells treated with Mepazine 10.54
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 10.34
Primary human trophoblast from term placenta 10.26
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 9.9
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 9.9
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 9.81
Targeting MTHFD2 in Acute Myeloid Leukemia 9.79
3’ Uridylation Expands miRNA Target Repertoire 9.78
Differentially expressed vascular development genes for iPSC-ECs from CDI 9.68
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 9.6
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 9.6
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 9.57
Global Mapping of Human RNA-RNA Interactions 9.54
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 9.43
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 9.43
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 9.34
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 9.27
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 9.21
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 9.19
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 9.16
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 9.15
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 9.11
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 9.09
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 9.09
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 9.08
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 9.03
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 9.0
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 8.91
The cohesin release factor WAPL restricts chromatin loop extension. 8.91
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 8.9
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 8.9
RNA-Seq with and without RNase treatment in PCa cell lines 8.82
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 8.73
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 8.73
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 8.67
Exploring the RNA landscape of endothelial exosomes 8.6
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 8.59
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 8.5
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 8.49
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 8.48
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 8.45
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 8.45
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 8.45
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 8.38
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 8.26
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 8.25
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 8.25
Effect of mitochondria deficiency on senescence-associated gene expression 8.13
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 8.09
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 8.08
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 8.05
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 8.05
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 8.04
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 8.03
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 8.03
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 8.03
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 8.01
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 7.96
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 7.96
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 7.93
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 7.92
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 7.92
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 7.92
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 7.89
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 7.87
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 7.85
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 7.82
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 7.82
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 7.8
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 7.78
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 7.78
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 7.77
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 7.76
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 7.76
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 7.75
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 7.75
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 7.74
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 7.72
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 7.71
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 7.7
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 7.7
LNCaP treated with iBET 7.69
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 7.69
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 7.69
Expression by CD133+ cells isolated from the adult human exocrine pancreas 7.66
High-throughput sequencing of PROMPT-enriched samples. 7.66
Transcriptomes of oxLDL exposed trained monocytes 7.61
oxLDL exposed trained monocytes 7.61
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 7.61
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 7.61
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 7.6
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 7.6
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 7.6
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 7.59
Rorc disruption in human FG pancreatic cancer cells 7.56
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 7.53
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 7.52
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 7.52
FBXW7 modulates stress response by post-translational modification of HSF1 7.5
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 7.5
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 7.48
Disruption of the exocyst induces podocyte loss and dysfunction 7.48
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 7.46
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 7.46
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 7.46
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 7.46
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 7.43
Electronic cigarettes 7.42
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 7.41
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 7.37
Gene expression regulated by CSA and CSB in neuroblastoma cell line 7.33
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 7.31
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 7.31
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 7.31
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 7.28
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 7.26
Global expression profiles in cardiac progenitor cells generated by ISX-9 7.26
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 7.26
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 7.19
Role of XRN2 ribonucleolytic activity in RNA metabolism 7.18
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 7.18
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 7.15
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 7.12
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 7.12
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 7.11
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 7.1
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 7.07
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 7.05
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 7.05
RNA-seq of RKO cells with cTAZ KO or putback 7.04
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 7.02
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 6.94
Peptidomimetic blockade of MYB in acute myeloid leukemia 6.94
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 6.88
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 6.85
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 6.81
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 6.78
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 6.74
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 6.74
mRNA expression in human DAOY cells 6.74
Global gene expression profile of dasatinib-resistant RCH-ACV cells 6.74
Transcriptional profile in human S. haematobium infection 6.72
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 6.69
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 6.69
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 6.62
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 6.61
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 6.54
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 6.54
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 6.53
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 6.52
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 6.49
Transcriptional landscape changes during human embryonic stem cell derivation 6.44
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 6.42
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 6.37
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 6.34
Molecular Criteria for Defining the Naive Human Pluripotent State 6.27
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 6.25
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 6.25
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 6.16
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 6.13
Gene expression profiling of leukemia cells following asparagine depletion 6.07
RNA polymerase in pre-B-ALL cell lines 6.04
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 6.03
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 6.02
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 5.97
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 5.93
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 5.93
K562 polyA RNA-Seq 5.9
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 5.89
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 5.89
Mapping interactions for the TNIP2 hub protein 5.87
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 5.87
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 5.82
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 5.82
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 5.8
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 5.8
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 5.75
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 5.7
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 5.62
RNA transcriptome analysis during HSV-1 infection 5.61
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 5.6
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 5.6
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 5.55
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 5.38
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 5.38
RNA-seq of naive and primed ES cells 5.37
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 5.34
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 5.34
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 5.34
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 5.34
Systematic discovery of endogenous human ribonucleoprotein complexes 5.33
Transcriptome analysis of kidney organoids 5.31
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 5.28
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 5.24
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 5.22
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 5.19
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 5.16
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 5.16
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 5.15
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 5.14
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 5.14
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 5.14
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 5.0
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 5.0
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 4.92
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 4.92
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 4.91
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 4.91
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 4.89
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 4.88
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 4.88
Regulation of protein translation during mitosis 4.87
The transcriptome effect of overexpressing EZH2 in MCF7 4.82
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 4.8
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 4.79
Lipid degradation promotes prostate cancer cell survival 4.74
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 4.68
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 4.66
Comparative Analysis of Cas9 Activators Across Multiple Species 4.63
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 4.6
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 4.6
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 4.58
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 4.53
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 4.5
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 4.49
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 4.49
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 4.49
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 4.48
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 4.41
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 4.39
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 4.36
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 4.36
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 4.34
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 4.29
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 4.27
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 4.24
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 4.15
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 4.12
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 4.09
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 4.09
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 4.06
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 4.01
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 3.92
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits 3.89
Capturing the Interactome of Newly Transcribed RNA 3.87
Capturing the Interactome of Newly Transcribed RNA (RICK) 3.87
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 3.81
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 3.81
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 3.79
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 3.77
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 3.77
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 3.76
Gene expression profile in breast cancer cells 3.76
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 3.76
single cell RNA-seq from GM12878 (ENCSR673UIY) 3.75
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 3.7
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 3.7
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 3.68
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 3.61
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 3.54
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 3.51
Regulatory network controlling tumor-promoting inflammation in human cancers 3.51
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 3.48
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 3.48
Human Treg NaCl stimulation 3.43
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 3.4
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 3.39
4sUDRB-seq: measuring transcription elongation and initiation genomewide 3.38
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 3.34
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 3.3
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 3.3
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 3.26
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 3.26
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 3.23
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 3.21
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 3.2
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 3.2
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 3.16
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 3.14
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 3.13
The Genetic Landscape of Diamond-Blackfan Anemia 3.12
TOP2B disturbed the quality of human oocytes with advanced maternal age 3.05
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 3.05
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 3.04
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 3.02
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 3.01
Conservative alteration of chromosomal expression pattern across human solid tumor types 3.0
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.98
Transcriptomes of human monocytes after ex vivo exposure to uric acid 2.94
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 2.91
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 2.89
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 2.89
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 2.83
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 2.79
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 2.78
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 2.72
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 2.71
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 2.68
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 2.63
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 2.6
RNA-Seq of PRMT1 overexpression ECA109 cells 2.58
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 2.56
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 2.55
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 2.54
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 2.54
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 2.52
Copper Regulation of HIF-1 Transcription Activity 2.52
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 2.52
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 2.5
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 2.45
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 2.43
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 2.35
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 2.31
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 2.25
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 2.25
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 2.19
RNA-Seq from human ILC transitional populations 2.18
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 2.18
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 2.17
Next generation sequencing of small RNAs isolated from exosomes in human semen 2.16
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 2.15
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 2.15
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 2.14
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 2.11
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 2.1
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 2.09
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 2.08
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 2.08
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 2.06
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 2.04
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 1.96
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 1.94
nELAVL HITS-CLIP in Alzheimer's Disease patients 1.92
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 1.88
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 1.86
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 1.84
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 1.84
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 1.82
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 1.81
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.79
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 1.77
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 1.76
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 1.76
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 1.76
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 1.74
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 1.72
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 1.71
Transposon-based construction of strand-specific RNA-seq libraries 1.66
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 1.64
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 1.61
Transcriptomic profiling of human peripheral blood-derived mast cells 1.61
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 1.6
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 1.6
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 1.59
Interaction between mitoNEET and NAF-1 in cancer cells 1.58
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 1.57
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 1.52
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 1.52
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 1.48
WNT signaling memory is required for ACTIVIN to function as a morphogen 1.43
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 1.41
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.39
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 1.33
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 1.31
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 1.29
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 1.28
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 1.24
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 1.22
ADAR1-editing of cellular and measles virus-derived duplex RNA 1.2
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 1.2
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 1.18
A code of mono-phosphorylation modulates the function of RB. 1.15
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 1.14
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 1.12
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 1.11
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 1.11
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 1.08
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.08
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 1.06
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 1.05
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.01
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 0.93
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.93
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.93
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 0.9
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 0.87
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.86
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 0.85
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.77
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.77
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 0.76
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.73
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.72
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.72
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 0.71
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.68
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.68
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.59
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 0.59
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.58
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 0.55
A single-cell transcriptome atlas of the human pancreas 0.53
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 0.5
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 0.5
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.46
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.4
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.39
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.37
An siRNA screen identifies CHD4 as a target for epigenetic therapy 0.37
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 0.36
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 0.36
HBEC-shp53-PCHD7 0.35
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.33
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 0.33
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 0.33
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.32
Human Tfh cell RNA bulk sequencing 0.3
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.28
RNA-seq of primary patient AML samples 0.28
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.26
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.25
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 0.14
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.14
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.14
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 0.13
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 0.13
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 0.12
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.06
Modulation of nonsense-mediated decay by rapamycin 0.03
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 0.02
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.02
Interphase condensins regulate ligand-depedent enhancer activation 0.02
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.02
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.01
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation